Navigation Links
AAHIVM Encouraged by TMC125 Approval
Date:2/4/2008

New HIV Medication Could Offer More Options for Treatment-Experienced

Patients

WASHINGTON, Feb. 4 /PRNewswire/ -- The American Academy of HIV Medicine (AAHIVM), a national organization of HIV-treating physicians, nurse practitioners and physician assistants, praised the accelerated U.S. Food and Drug Administration (FDA) approval of the anti-HIV medication TMC125 (etravirine), the first non-nucleoside reverse transcriptase inhibitor (NNRTI) to be introduced in nearly 10 years, and the first to show antiviral activity in treatment-experienced adult patients with NNRTI-resistant virus. NNRTI drug resistance occurs when HIV develops mutations that partially or completely stop the NNRTI from binding to the reverse transcriptase enzyme, causing the drug to lose effectiveness.

"With the FDA's accelerated approval of TMC125, we are encouraged by the increased treatment options that are now available for our patients," said AAHIVM Board Chair Jeffrey Schouten, MD, AAHIVS. "With antiretroviral therapy now in its third decade, HIV care providers have increasing concern over the cross-resistance of the NNRTI class. A patient resistant to one NNRTI is generally resistant to the other NNRTIs available, which significantly limits our options with our longtime and treatment-experienced patients. This drug may also be very useful for people who are infected with an NNRTI-resistant strain of HIV which is not uncommon. TMC125 offers HIV care providers another treatment option that could dramatically increase the capacity for continued success in their patients' long-term HIV care."

FDA-accelerated approval procedures allow for earlier approval of drugs that provide a meaningful therapeutic advantage over existing treatment for serious or life-threatening diseases. Longer-term data will be required before the FDA can consider traditional approval of TMC125. Dr. Schouten emphasized the importance of closely monitoring chang
'/>"/>

SOURCE The AIDS Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Families Encouraged to Enjoy Healthy Kids Fest January 12 at the Blue Cross RiverRink
2. Parents Encouraged to Set an Example for Their Teens and Help Stop Underage Drinking
3. New York City Cancer Patients, Survivors and Care Givers Encouraged to Keep Going(R)
4. Radiologists encouraged to look beyond cancer for clinically unseen diseases
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
7. Researchers query FDA about updating requirements for drug approval
8. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
9. ATS Medical Provides Update on First Generation Tissue Valve Approval
10. Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009
11. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 ... has joined the firm in a newly created position ... accounts and support organizations committed to improving employee retention ... a wealth of marketing experience and most recently worked ... up that was recently taken over a global mobile ...
(Date:6/2/2015)... Camarillo, Calif. (PRWEB) June 02, 2015 ... designing and manufacturing high performance connector solutions and ... MINI-SNAP® advanced connector solutions to the US market. ... connector with Push-Pull locking capabilities. The self- securing ... range of demanding applications that require significant customization ...
(Date:6/2/2015)... Residents of Monarch Landing in Naperville ... a fitness class, do yoga, play volleyball, or participate ... for the Alzheimer’s Association’s Walk to End Alzheimer’s on ... part in a challenge to exercise for 60 days, ... company. , While the walk will raise awareness of ...
(Date:6/2/2015)... The Radiosurgery Society® (RSS), a ... RSSearch® Patient Registry evaluating the treatment patterns and ... the treatment of centrally located primary non-small cell ... The study, published in the May, 2015, issue ... patients with 114 centrally located lung tumors who ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising ... the UNMC to support ovarian cancer research conducted by Cheng ... of the Colleen’s Dream Foundation Board of Directors. , Cundiff ... date for Colleen’s Dream Foundation and they couldn’t have picked ... Wang is a rising star in the ovarian cancer world,” ...
Breaking Medicine News(10 mins):Health News:Insightlink Communications Appoints New Director of Marketing and Client Engagement 2Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3
... the research bolsters the idea that humans suffering from ... help preserve function by adding antioxidants to their diet, ... devised a new cell-based gene therapy technique that could ... these diseases. , The work, led by Scripps ...
... Corporation (Nasdaq: MASI ), the inventor of ... today announced that its management is scheduled to present ... Stock Conference at The Ritz-Carlton, Laguna Niguel in Dana ... a.m. PT. A live audiocast of the presentation will ...
... SOBeFiT Magazine, the first South Florida,publication dedicated to providing ... sports for men and women, will host its sold-out, ... presented by The Sports,Club/LA, as part of the series ... On February 8th, 2009, hundreds of ...
... not immediately order routine scans for low-back pain unless ... in the Oregon Evidence-Based Practice Center at Oregon Health ... this week,s edition of the The Lancet . ... scans in patients with low-back pain but no indication ...
... Corporation,(Nasdaq: VOLC ), a leader in the ... treatment of coronary and peripheral artery,disease, today announced that ... and all of fiscal 2008 on Tuesday, February 17. ... a conference call to discuss its financial results,and operating ...
... of its top priorities--reforming the nation,s health care system--twelve pharmacy stakeholder ... Reform, which will be announced during a media briefing on February ... ... Washington, DC (Vocus) February 6, 2009 -- As the new administration ...
Cached Medicine News:Health News:Team led by Scripps Scientists increases understanding of two types of blindness 2Health News:Team led by Scripps Scientists increases understanding of two types of blindness 3Health News:Team led by Scripps Scientists increases understanding of two types of blindness 4Health News:Team led by Scripps Scientists increases understanding of two types of blindness 5Health News:Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference 2Health News:SOBeFiT Magazine Promotes its Launch With First Annual 5K Run+Walk & Fitness Festival in South Beach 2Health News:SOBeFiT Magazine Promotes its Launch With First Annual 5K Run+Walk & Fitness Festival in South Beach 3Health News:Routine scans for low-back pain do not improve outcomes 2Health News:Routine scans for low-back pain do not improve outcomes 3Health News:Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast 2Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 2Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 3
(Date:6/2/2015)... June 2, 2015 Today AmerisourceBergen, a global ... distribution centers in Olive Branch, MS ... Newburgh, NY . The facilities will operate ... improve product access, increase supply chain efficiency and enhance ... of the company,s ongoing investments, more than $1 billion ...
(Date:6/2/2015)... , June 02, 2015 Research and ... of the "Motion Simulation Market by Type ... Three DOF, and Six DOF), Application (Automotive, Defense, ... Region - Forecast to 2020 " report ... is considered to have matured enough for commercial ...
(Date:6/2/2015)...  Nektar Therapeutics (NASDAQ: NKTR ) and The ... a research collaboration that includes a Phase 1/2 clinical ... preferentially stimulate production of CD8-positive T cells, which are ... which is also known as the Interleukin-2 receptor beta ... to increase proliferation of these effector T cells. 1 ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Global Motion Simulation Market 2015-2020 - Type, Degree of Freedom, Application, and Regional Analysis 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 4Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 5Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 6
... Inc. , an emerging medical device developer of women,s ... clearance for the FemChec™ Pressure Management Device, the first ... confirmation test after a permanent sterilization procedure is performed. ... pressure to 200 mmHg, providing confidence to the physician ...
... of the public and private healthcare industry have never been ... a new book , "Health Industry Communication: New Media, ... Christina Mazzola Nicols of Ketchum , one of the ... this fall from Jones & Bartlett Learning , provides ...
Cached Medicine Technology:Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device 2New Book Highlights Opportunities for Healthcare Industry Communications 2New Book Highlights Opportunities for Healthcare Industry Communications 3New Book Highlights Opportunities for Healthcare Industry Communications 4New Book Highlights Opportunities for Healthcare Industry Communications 5
Small golf club shape tip with sharp edge. Flat serrated handle with polished finish. Most popular size or model....
Threaded ends permit guarding the needle and gouge within the handle. Set consists of one each : E0828 A needle tip, E0828 B gauge tip and E0828 C handle. Most popular size or model....
0.5 mm replacement burr for Algerbrush rust ring remover (E0815 A). Burr can also be used with Algerbrush rust ring remover (E0815 B). Dull finish....
Short 12 mm taper with needle type tip. Stainless steel. Round smooth handle with polished finish. Overall length: 2.8 inches....
Medicine Products: